Aims and objectives

The ESCMID Study Group for Host and Microbiota Interactions (ESGHAMI) is leading the way in bridging diagnostics, clinical research, and scientific studies across the relatively new field of microbiota research in Europe. Together, we seek to understand the clinical significance of host-microbiota associated diseases and health, and explore relevant therapeutic interventions. Our research covers:

  • Intestinal, urogenital, respiratory, and skin microbiota of both humans and animals
  • Interactions of microbiota with the host immune response

Activities and resources

ESGHAMI Newsletter, Spring 2024, April 2024

Download


ESGHAMI Newsletter, Spring 2023, April 2023

Download


ESGHAMI Newsletter, Spring 2023, May 2023

Download


ESGHAMI Newsletter, Summer 2023, June 2023

Download


ESGHAMI Newsletter, Summer 2023, September 2023

Download


ESGHAMI Newsletter, Winter 2023, December 2023

Download

Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.

van Prehn J, van Werkhoven CH, Skinner AM, Guery B, Dubberke ER, Kuijper EJ. Clinical Microbiology and Infection 2024;30(2):165–169.

Go to publication


Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.

van Prehn J, Fitzpatrick F, Kuijper EJ. Lancet Gastroenterol Hepatol. 2022;7(12):1083–1091.

Go to publication


Bacteriophage therapy in humans.

Nir-Paz R, Kuijper EJ. Clin Microbiol Infect. 2023;29(6):679–681.

Go to publication


Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023.

Benech N, Barbut N, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, hHeritage J, Guery B, Kuijper E. Clinical Microbiology and Infection. 2023:S1198-743X(23)00597-9.

Go to publication

Faecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma


Update on Live biotherapeutic products and FMT-like treatments for recurrent Clostridioides difficile infections

21 June 2023

Go to webinar

Microbiome from benchtop to bedside technical workshop

Executive Committee

  Ed J. Kuijper

Ed J. Kuijper

Chairperson
LUMC. Medical Microbiology.
Leiden, Netherlands
  Christophe Van Dijck

Christophe Van Dijck

Secretary
Institute of Tropical Medicine Antwerp. Clinical Sciences.
Antwerp, Belgium
  Lesley Hoyles

Lesley Hoyles

Treasurer
Nottingham Trent University. Biosciences.
Nottingham, United Kingdom

Contact

If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form